circRNA basic information
circBase ID: -
Name: -
Synonym: circRNA_100395
Host Gene: -
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0001056
MONDO name: gastric cancer
Disease details: gastric cancer
Disease DO ID:
10534
Disease MeSH ID:
-
Disease NCIt ID:
C9331
Disease ICD11 ID:
1397617262
Disease OMIM ID:
613659
Species: Human
Species details: Homo sapiens
Tissue specimen:

GC tissues; normal tissue samples

Cell lines:

293T; GES-1; HGC-27; MKN45; NCI-N87; SNU-5; AGS

In vivo animal model:

-

circRNA-disease information
Expression pattern:
DN
Associated gene: PTEN, PI3K, AKT, p-AKT
Associated microRNA: miR-142-3p
Biological function: tumor suppressor; inhibits proliferation; promotes apoptosis; inhibits migration and invasion
Molecular mechanism: Acts as a miRNA sponge for miR-142-3p and regulates PTEN-PI3K/AKT signaling
Biological pathway or process:

PI3K/AKT (inhibits); proliferation (inhibits); apoptosis (promotes); migration (inhibits); invasion (inhibits); ceRNA regulation (other)

Detected method:
Q
Validation methods:

RT-qPCR; Clinical Sample Validation; Survival Analysis; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot

Clinical significance:

Low expression levels of circRNA_100395 were associated with poor tumor differentiation, advanced Tumor-Node-Metastasis stage, lymph node metastasis and shorter overall survival time.

Description:

circRNA_100395 is down-regulated in gastric cancer tissues/cell lines, and higher circRNA_100395 expression is associated with better overall survival. Functionally, circRNA_100395 overexpression suppresses proliferation, migration and invasion and promotes apoptosis, at least partly by sponging miR-142-3p and inhibiting the PTEN-PI3K/AKT signaling axis.

Confidence score:

0.7126

Other information
Title:

Upregulation of circRNA_100395 sponges miR-142-3p to inhibit gastric cancer progression by targeting the PI3K/AKT axis.

Journal: Oncology letters
Published: 2021
PubMed ID: 33841580
Study type:

combined biological and clinical study

Data availability: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability: -